Skip to main content

SkyView Investment Advisors, LLC

Position in NVO — Novo Nordisk A S

CIK 1848237 SHREWSBURY, NJ

Position in NVO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$698,617
-$250,752 QoQ
Shares Held
19,010
+1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

SkyView Investment Advisors, LLC holds $5,693,586 across 8 Drug Manufacturers - General names. NVO ranks #4 (12.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NVO
Novo Nordisk A S
This page
19,010 $698,617

All Filings in NVO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $698,617 19,010
2025-12-31 $949,369 18,659
2025-09-30 $1,018,629 18,357
2025-06-30 $1,237,735 17,933
2025-03-31 $1,220,755 17,580
2024-06-30 $2,016,202 14,125
2024-03-31 $1,807,358 14,076
2023-09-30 $1,124,381 12,364
2023-06-30 $1,671,865 10,331
2023-03-31 $1,194,344 7,505
2022-12-31 $997,726 7,372
2022-09-30 $739,653 7,424
2022-06-30 $748,920 6,721
2022-03-31 $439,980 3,962
2021-12-31 $434,560 3,880
2021-09-30 $372,518 3,880
2021-06-30 $325,027 3,880
2021-03-31 $261,589 3,880
2020-12-31 $271,018 3,880